Acorda Therapeutics Inc reiterates FY 2014 AMPYRA net revenue guidance


Tuesday, 6 May 2014 06:00am EDT 

Acorda Therapeutics Inc:Reiterates FY 2014 guidance for AMPYRA net revenue of $328-$335 mln. 

Company Quote

39.37
0.9 +2.34%
11:20am EST